Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorma Isola

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Methods in Molecular Medicine|April 6, 2004
Chromogenic in situ hybridization in tumor pathologyJorma Isola, Minna Tanner
Journal of Digital Imaging|May 6, 2009
Linking whole-slide microscope images with DICOM by using JPEG2000 interactive protocolVilppu J Tuominen, Jorma Isola
Journal of Digital Imaging|November 14, 2007
The application of JPEG2000 in virtual microscopyVilppu J Tuominen, Jorma Isola
Clinical Breast Cancer|September 23, 2003
Topoisomerase II alpha as a marker predicting the efficacy of anthracyclines in breast cancer: are we at the end of the beginning?Angelo Di Leo, Jorma Isola
Acta Oncologica (Stockholm, Sweden)|September 2, 2008
Analyzing toposimerase II-alpha and HER-2/neu co-amplification seems to be of limited value in epithelial ovarian cancerJohanna Mäenpää, Minna Tanner, Jorma Isola
Duodecim; Laaketieteellinen Aikakauskirja|December 19, 2015
[Clinical pathology on the verge of virtual microscopy]Teemu Tolonen, Juha Näpänkangas, Jorma Isola
Cancer Research|August 28, 2003
Haplo-insufficiency of BRCA1 in sporadic breast cancerSynnöve Staff, Jorma Isola, Minna Tanner
Breast Cancer Research : BCR|June 3, 2014
Trastuzumab emtansine: mechanisms of action and drug resistanceMark Barok, Heikki Joensuu, Jorma Isola
Duodecim; Laaketieteellinen Aikakauskirja|March 30, 2011
[Targeted cytotoxic drugs emerging for cancer therapy]Teemu T Junttila, Minna Tanner, Jorma Isola
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 2, 2005
Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumorsMervi Laakso, Niklas Loman, Ake Borg, et al.
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Methods in Molecular Medicine|April 6, 2004
Chromogenic in situ hybridization in tumor pathologyJorma Isola, Minna Tanner
Journal of Digital Imaging|May 6, 2009
Linking whole-slide microscope images with DICOM by using JPEG2000 interactive protocolVilppu J Tuominen, Jorma Isola
Journal of Digital Imaging|November 14, 2007
The application of JPEG2000 in virtual microscopyVilppu J Tuominen, Jorma Isola
Clinical Breast Cancer|September 23, 2003
Topoisomerase II alpha as a marker predicting the efficacy of anthracyclines in breast cancer: are we at the end of the beginning?Angelo Di Leo, Jorma Isola
Acta Oncologica (Stockholm, Sweden)|September 2, 2008
Analyzing toposimerase II-alpha and HER-2/neu co-amplification seems to be of limited value in epithelial ovarian cancerJohanna Mäenpää, Minna Tanner, Jorma Isola
Duodecim; Laaketieteellinen Aikakauskirja|December 19, 2015
[Clinical pathology on the verge of virtual microscopy]Teemu Tolonen, Juha Näpänkangas, Jorma Isola
Cancer Research|August 28, 2003
Haplo-insufficiency of BRCA1 in sporadic breast cancerSynnöve Staff, Jorma Isola, Minna Tanner
Breast Cancer Research : BCR|June 3, 2014
Trastuzumab emtansine: mechanisms of action and drug resistanceMark Barok, Heikki Joensuu, Jorma Isola
Duodecim; Laaketieteellinen Aikakauskirja|March 30, 2011
[Targeted cytotoxic drugs emerging for cancer therapy]Teemu T Junttila, Minna Tanner, Jorma Isola
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 2, 2005
Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumorsMervi Laakso, Niklas Loman, Ake Borg, et al.
Pageof 15